Back

Results - Announcements

Sales decline 9.74% to Rs 134.00 crore

Syncom Formulations (India) standalone net profit rises 40.40% in the March 2026 quarter

23-May-2026, 07:21
Net profit of Syncom Formulations (India) rose 40.40% to Rs 24.57 crore in the quarter ended March 2026 as against Rs 17.50 crore during the previous quarter ended March 2025. Sales declined 9.74% to Rs 134.00 crore in the quarter ended March 2026 as against Rs 148.46 crore during the previous quarter ended March 2025.

For the full year,net profit rose 55.54% to Rs 76.01 crore in the year ended March 2026 as against Rs 48.87 crore during the previous year ended March 2025. Sales rose 5.12% to Rs 486.57 crore in the year ended March 2026 as against Rs 462.85 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	134.00	148.46	-10	486.57	462.85	5
OPM %	16.03	11.77	-	15.86	11.56	-
PBDT	35.34	24.28	46	107.01	69.83	53
PBT	32.86	22.99	43	100.48	64.64	55
NP	24.57	17.50	40	76.01	48.87	56